Skip to content
Triangle logo TriangleGet started
← Full study record

NCT05537766 · OUTCOME

Substudy A: PR Rate Determined by Central Assessment Per the Sixth International Workshop in WM

Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies · Source last updated 2026-03-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Up to 2 years

What was measured

PR rate was defined as percentage of participants who achieve PR.

Analysis population: Substudy A was withdrawn, therefore no participants were enrolled in it. Hence, data is not available.

Groups in this outcome

Substudy A (Relapsed/Refractory Waldenstrom Macroglobulinemia): Brexucabtagene Autoleucel

This substudy was withdrawn; therefore, no participants were enrolled.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Substudy A (Relapsed/Refractory Waldenstrom Macroglobulinemia): Brexucabtagene Autoleucel0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
description
PR rate was defined as percentage of participants who achieve PR.
groups
  1. description
    This substudy was withdrawn; therefore, no participants were enrolled.
    id
    OG000
    title
    Substudy A (Relapsed/Refractory Waldenstrom Macroglobulinemia): Brexucabtagene Autoleucel
population Description
Substudy A was withdrawn, therefore no participants were enrolled in it. Hence, data is not available.
reporting Status
POSTED
time Frame
Up to 2 years
title
Substudy A: PR Rate Determined by Central Assessment Per the Sixth International Workshop in WM
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice